Farhana Musarrat

The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

Farhana Musarrat, Vladimir N. Chouljenko, Achyut Dahal et al. · Journal of Medical Virology · 2020 · 158 citations · Full text

Covid‐19 Infections, Immunodeficiencies, Viral Pathogenesis +20

CTCF Binding Sites in the Herpes Simplex Virus 1 Genome Display Site-Specific CTCF Occupation, Protein Recruitment, and Insulator Function

Shannan D. Washington, Farhana Musarrat, Monica K. Ertel et al. · Journal of Virology · 2018 · 48 citations · Full text

The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes

Farhana Musarrat, Nithya Jambunathan, Paul J. F. Rider et al. · Journal of Virology · 2018 · 43 citations · Full text

PEDF plus DHA modulate inflammation and stimulate nerve regeneration after HSV-1 infection

Jiucheng He, Donna M. Neumann, Azucena H Kakazu et al. · Experimental Eye Research · 2017 · 37 citations · Full text

Ocular Disease, Immunology, Immune Regulation +19

Cellular and Viral Determinants of Herpes Simplex Virus 1 Entry and Intracellular Transport toward the Nuclei of Infected Cells

Farhana Musarrat, Vladimir N. Chouljenko, Konstantin G. Kousoulas · Journal of Virology · 2021 · 25 citations · Full text